Compounds > cordycepin
Page last updated: 2024-08-17

cordycepin and 2019 Novel Coronavirus Disease

cordycepin has been researched along with 2019 Novel Coronavirus Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's6 (100.00)2.80

Authors

AuthorsStudies
Chen, H; Chen, X; Cheng, J; Fu, J; Fu, S; He, J; Li, D; Liu, S; Liu, X; Zhang, L1
Chen, H; Cheng, J; Du, J; Fu, J; Fu, S; Guo, K; He, J; He, T; Li, D; Li, T; Liu, S; Liu, X; Liu, Z; Qian, J; Song, B; Tan, Q; Zhang, L; Zhou, B1
Cheng, J; Fu, J; He, J; Li, T; Liu, S; Liu, X; Liu, Z; Mei, Z; Tan, Q; Wang, K; Wei, C1
Chen, H; Cheng, J; Du, J; Fu, J; He, T; Zhang, L; Zhang, W1
Aggarwal, R; Verma, AK1
Bibi, S; Hasan, MM; Papadakos, SP; Wang, YB; Yu, H1

Other Studies

6 other study(ies) available for cordycepin and 2019 Novel Coronavirus Disease

ArticleYear
COVID-19 disease and malignant cancers: The impact for the
    International journal of biological sciences, 2021, Volume: 17, Issue:14

    Topics: Antineoplastic Agents; Cell Line, Tumor; COVID-19; Deoxyadenosines; Disease Susceptibility; Endoplasmic Reticulum Chaperone BiP; Furin; Humans; Neoplasms; Protein Isoforms; Serine Endopeptidases

2021
Impact of
    Molecules (Basel, Switzerland), 2022, Nov-01, Volume: 27, Issue:21

    Topics: Adenosine; COVID-19; COVID-19 Drug Treatment; Humans; Lung Neoplasms; Male; Mutation; Prognosis; Prostatic Neoplasms; SARS-CoV-2; Serine Endopeptidases

2022
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17.
    Molecules (Basel, Switzerland), 2022, Dec-19, Volume: 27, Issue:24

    Topics: ADAM17 Protein; Angiotensin-Converting Enzyme 2; Antiviral Agents; COVID-19; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2

2022
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m
    International journal of oncology, 2023, Volume: 62, Issue:3

    Topics: Adenocarcinoma; Adenosine; Carcinoma, Hepatocellular; COVID-19; Dipeptidyl Peptidase 4; Female; Humans; Immunity; Liver Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Pancreatic Neoplasms; Pandemics; Prospective Studies; SARS-CoV-2; Skin Neoplasms

2023
Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
    Chemical biology & drug design, 2021, Volume: 97, Issue:4

    Topics: Antiviral Agents; Binding Sites; Cell Line; Cell Survival; COVID-19; COVID-19 Drug Treatment; Deoxyadenosines; Drug Repositioning; Humans; Machine Learning; Molecular Docking Simulation; Protease Inhibitors; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Viral Matrix Proteins

2021
Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp).
    Current medicinal chemistry, 2022, Volume: 29, Issue:1

    Topics: Antiviral Agents; COVID-19; Deoxyadenosines; Humans; Molecular Docking Simulation; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2

2022